Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

David Truswell

David Truswell

Somefreshthinking Consultancy UK

Jan Ulfberg

Jan Ulfberg

Capio Sleep Center Sweden

Hari Shanker Sharma

Hari Shanker Sharma

Uppsala University Sweden

Hua P Su

Hua P Su

MSD Research Labs USA

Istvan Berczi

Istvan Berczi

University of Manitoba Canada

Michael V Ugrumov

Michael V Ugrumov

Institute of Developmental Biology RAS Russia

Joel B Schachter

Joel B Schachter

Merck Research Laboratories USA

Ni Hong

Ni Hong

Soochow University China

Neuropharmacology 2018

Sessions/Tracks

Track 1: Neuroimmunology and Neuroinflammation

It deals with a branch of immunology concerned with the interactions between immunological and nervous system functions also associated autoimmune diseases. . Encephalitis is acute inflammation of the brain resulting from a viral infection or an autoimmune disease. Transverse myelitis is a pathogenetically heterogeneous inflammatory disorder in which spinal cord is affected. Huntington disease is a progressive brain disorder that causes uncontrolled movements, emotional problems, and loss of thinking ability.

Related Conferences: Neuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Meetings | Neuropharmacology Congress

12th Pharmaceutical Sciences and Pharma Industry Conference February 26- 27 2018, London, UK; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; Mississippi Addictions Conference, February 28 -March 02 2018, Jackson, USA; British NeuroPsychiatry Meeting, March 01- 02 2018, London, UK; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, USA;  26th European Psychiatric Meeting, 3March 03-06 2018, Nice, France;  20th Parkinson’s Disease and Movement Disorders symposium, May 14 - 15, 2018, London, UK

Related Societies:

Societies in USA: American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, Alzheimer's Association

Societies in Europe: Alzheimer Europe, European Federation of Neurological SocietiesNational Institute of Neurological Disorders and Stroke, Australian Neuroscience SocietyAmerican Clinical Neurophysiology Society

Societies in Asia: Asian Society Against Dementia (ASAD),  Neurological Society of India, Neurology Asia, Austrian society of neurology, Asia Pacific Stroke Organisation

Track 2: Neural Stem Cell

Neural stem cells (NSCs) offer a unique and powerful tool for basic research and regenerative medicine. To date the need to accomplish this has just been met to some degree for neurons got from embryonic undeveloped cells or iPS cells, and still, after all that the information is not of a quality to justify clinical trials. The issue is that, while the cells that can be made in the lab resemble the ones required, they frequently do not have certain fundamental attributes.

Related Conferences: Neuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany, 12th Pharmaceutical Sciences and Pharma Industry Conference February 26- 27 2018, London, UK; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018        Berlin, Germany; Mississippi Addictions Conference, February 28 -March 02 2018, Jackson, USA; 26th European Psychiatric Meeting, March 03-06 2018, Nice, France;  British NeuroPsychiatry Meeting, March 01- 02 2018, London, UK; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, USA;  20th Parkinson’s Disease and Movement Disorders symposium, May 14 - 15, 2018, London, UK

Related Societies:

Societies in USA: American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, Alzheimer's Association

Societies in Europe: Alzheimer Europe, European Federation of Neurological SocietiesNational Institute of Neurological Disorders and Stroke, Australian Neuroscience SocietyAmerican Clinical Neurophysiology Society

Societies in Asia: Asian Society Against Dementia (ASAD),  Neurological Society of India, Neurology Asia, Austrian society of neurology, Asia Pacific Stroke Organisation

Track 3: Neuroethics

It includes the social, legal and ethical consequences of advances in neuroscience. It is the amalgamation of neuroscience with ethical thoughts. The ethics of neurocognitive includes brain interventions and imagining, neurological treatments and consciousness disorders.

Related Conferences: Neuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018    Berlin, Germany; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany, 12th Pharmaceutical Sciences and Pharma Industry Conference February 26- 27 2018, London, UK; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 20th Parkinson’s Disease and Movement Disorders symposium, May 14 - 15, 2018, London, UK Mississippi Addictions Conference, February 28 -March 02 2018, Jackson, USA; 26th European Psychiatric Meeting, March 03-06 2018, Nice, France;  British NeuroPsychiatry Meeting, March 01- 02 2018, London, UK; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, USA

Related Societies:

Societies in USA: American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, Alzheimer's Association

Societies in Europe: Alzheimer Europe, European Federation of Neurological SocietiesNational Institute of Neurological Disorders and Stroke, Australian Neuroscience SocietyAmerican Clinical Neurophysiology Society

Societies in Asia: Asian Society Against Dementia (ASAD),  Neurological Society of India, Neurology Asia, Austrian society of neurology, Asia Pacific Stroke Organisation

Track 4: Clinical Neuropharmacology

It is the science that studies the features, properties, responses and uses of drugs mainly their therapeutic effect in humans along with toxicology, pharmacodynamics and pharmacokinetics. It also includes drug abuse, pain and hypothalamic releasing factors.

Related Conferences: Neuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany, 12th Pharmaceutical Sciences and Pharma Industry Conference February 26- 27 2018, London, UK; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018  Berlin, Germany; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 20th Parkinson’s Disease and Movement Disorders symposium, May 14 - 15, 2018, London, UK Mississippi Addictions Conference, February 28 -March 02 2018, Jackson, USA; 26th European Psychiatric Meeting, March 03-06 2018, Nice, France;  British NeuroPsychiatry Meeting, March 01- 02 2018, London, UK; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, USA

Related Societies:

Societies in USA: American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, Alzheimer's Association

Societies in Europe: Alzheimer Europe, European Federation of Neurological SocietiesNational Institute of Neurological Disorders and Stroke, Australian Neuroscience SocietyAmerican Clinical Neurophysiology Society

Societies in Asia: Asian Society Against Dementia (ASAD),  Neurological Society of India, Neurology Asia, Austrian society of neurology, Asia Pacific Stroke Organisation

Track 5: Psychopharmacology

Psychopharmacology is the learning of the effects of medication on the psyche (psychology), observing changed behaviors and how molecular events are manifest in a measurable behavioral form. Neurogenesis and repair deal with other aspects on the indications for medications prescribed to address psychiatric and behavioral problems. The treatments may cause side effects such as induction of the metabolic syndrome, type II diabetes related to the medications prescribed for management of psychiatric and behavioural disorders and disturbances. Schizophrenia is such a disorder which affects the thinking and acting ability of a person caused by viral infection, genetically or by immune disorder.

Related Conferences: Neuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

12th Pharmaceutical Sciences and Pharma Industry Conference February 26- 27 2018, London, UK; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; Mississippi Addictions Conference, February 28 -March 02 2018, Jackson, USA; British NeuroPsychiatry Meeting, March 01- 02 2018, London, UK; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, USA;  26th European Psychiatric Meeting, 3March 03-06 2018, Nice, France;  20th Parkinson’s Disease and Movement Disorders symposium, May 14 - 15, 2018, London, UK

Related Societies:

Societies in USA: American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, Alzheimer's Association

Societies in Europe: Alzheimer Europe, European Federation of Neurological SocietiesNational Institute of Neurological Disorders and Stroke, Australian Neuroscience SocietyAmerican Clinical Neurophysiology Society

Societies in Asia: Asian Society Against Dementia (ASAD),  Neurological Society of India, Neurology Asia, Austrian society of neurology, Asia Pacific Stroke Organisation

Track 6: Neurochemical Transmission

Neurochemistry is the specific study of neurochemicals, including neurotransmitters and other molecules that include psychopharmaceuticals, neuropeptides, or gastrotransmitters that influence the function of neurons. It also deals how these neurochemicals influence the network of neural operation. The studies include micro-macro connection between the analysis of organic compounds active in the nervous system and neural processes such as cortical plasticity, neurogenesis and neural differentiation, synapses, autism and intellectual disability, interneuronal coordination, interaction of drugs and its effect on summation and cotransmission process and advances in astrocyte-neuron interactions in health. Astrocyte dysfunction results into neurodegenerative diseases, stroke, epilepsy, migraine and neuroinflammatory diseases.

Related Conferences: Neuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26- 27 2018, London, UK; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; Mississippi Addictions Conference, February 28 -March 02 2018, Jackson, USA; British NeuroPsychiatry Meeting, March 01- 02 2018, London, UK; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, USA;  26th European Psychiatric Meeting, 3March 03-06 2018, Nice, France;  20th Parkinson’s Disease and Movement Disorders symposium, May 14 - 15, 2018, London, UK

Related Societies:

Societies in USA: American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, Alzheimer's Association

Societies in Europe: Alzheimer Europe, European Federation of Neurological SocietiesNational Institute of Neurological Disorders and Stroke, Australian Neuroscience SocietyAmerican Clinical Neurophysiology Society

Societies in Asia: Asian Society Against Dementia (ASAD),  Neurological Society of India, Neurology Asia, Austrian society of neurology, Asia Pacific Stroke Organisation

Track 7: Behavioral and Addiction Neuropharmacology

It is the study of drug dependence and how drug addiction affects the human mind, anxiety and autism, Measuring neural activity in Drug abuse, Alcoholism- tolerance to and physical dependence, and properties are mediated through its effects on dopamine neurons in the mesolimbic reward pathway, which connects the ventral tegmental area to the nucleus accumbens, Post-traumatic stress disorder and borderline personality disorder, clinical depression and enhanced treatments.

Related Conferences: Neuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26- 27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; Mississippi Addictions Conference, February 28 -March 02 2018, Jackson, USA; British NeuroPsychiatry Meeting, March 01- 02 2018, London, UK; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, USA;  26th European Psychiatric Meeting, 3March 03-06 2018, Nice, France;  20th Parkinson’s Disease and Movement Disorders symposium, May 14 - 15, 2018, London, UK

Related Societies:

Societies in USA: American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, Alzheimer's Association

Societies in Europe: Alzheimer Europe, European Federation of Neurological SocietiesNational Institute of Neurological Disorders and Stroke, Australian Neuroscience SocietyAmerican Clinical Neurophysiology Society

Societies in Asia: Asian Society Against Dementia (ASAD),  Neurological Society of India, Neurology Asia, Austrian society of neurology, Asia Pacific Stroke Organisation

Track 8: Neurotechnology

It is the measurement and analysis of chemical and electrical signals of nervous system. It includes neurocircuitary analysis, novel trans-synaptic tracing approaches, advancements of optical techniques, neuromodulation and transcranial magnetic stimulation. Neurotechnology plays a crucial role in diagnostics and identification of nervous activities.

Related Conferences: Neuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26- 27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; Mississippi Addictions Conference, February 28 -March 02 2018, Jackson, USA; British NeuroPsychiatry Meeting, March 01- 02 2018, London, UK; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, USA;  26th European Psychiatric Meeting, 3March 03-06 2018, Nice, France;  20th Parkinson’s Disease and Movement Disorders symposium, May 14 - 15, 2018, London, UK

Related Societies:

Societies in USA: American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, Alzheimer's Association

Societies in Europe: Alzheimer Europe, European Federation of Neurological SocietiesNational Institute of Neurological Disorders and Stroke, Australian Neuroscience SocietyAmerican Clinical Neurophysiology Society

Societies in Asia: Asian Society Against Dementia (ASAD),  Neurological Society of India, Neurology Asia, Austrian society of neurology, Asia Pacific Stroke Organisation

Track 9: Neuroendocrinology

It is the study of interactions between the nervous system and the endocrine system, also biological features of the cells involved and their communications. Most Important aspects of neuroendocrinology are insulin receptor and hypothalamic programming; stress, coping and interactions, neuro-endocrine-immune symphony, pituitary structure and hormone secretion.

Related Conferences: Neuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

12th Pharmaceutical Sciences and Pharma Industry Conference February 26- 27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy;; 13th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; Mississippi Addictions Conference, February 28 -March 02 2018, Jackson, USA; British NeuroPsychiatry Meeting, March 01- 02 2018, London, UK; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, USA;  26th European Psychiatric Meeting, 3March 03-06 2018, Nice, France;  20th Parkinson’s Disease and Movement Disorders symposium, May 14 - 15, 2018, London, UK

Related Societies:

Societies in USA: American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, Alzheimer's Association

Societies in Europe: Alzheimer Europe, European Federation of Neurological SocietiesNational Institute of Neurological Disorders and Stroke, Australian Neuroscience SocietyAmerican Clinical Neurophysiology Society

Societies in Asia: Asian Society Against Dementia (ASAD),  Neurological Society of India, Neurology Asia, Austrian society of neurology, Asia Pacific Stroke Organisation

Track 10: Alzheimer's Disease and Dementia

Alzheimer's is a type of dementia that causes problems with memory, thinking and behaviour. Symptoms usually develop slowly and become severe enough to interfere with daily tasks. Amyloid plaques are also found in the brain of Alzheimer patients. Neurocognitive effects associated with therapeutic drugs and animal cognition and behaviour - Fear and aversive learning and memory.

Related Conferences: Neuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26- 27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy;; 13th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; Mississippi Addictions Conference, February 28 -March 02 2018, Jackson, USA; British NeuroPsychiatry Meeting, March 01- 02 2018, London, UK; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, USA;  26th European Psychiatric Meeting, 3March 03-06 2018, Nice, France;  20th Parkinson’s Disease and Movement Disorders symposium, May 14 - 15, 2018, London, UK

Related Societies:

Societies in USA: American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, Alzheimer's Association

Societies in Europe: Alzheimer Europe, European Federation of Neurological SocietiesNational Institute of Neurological Disorders and Stroke, Australian Neuroscience SocietyAmerican Clinical Neurophysiology Society

Societies in Asia: Asian Society Against Dementia (ASAD),  Neurological Society of India, Neurology Asia, Austrian society of neurology, Asia Pacific Stroke Organisation

 

Track 11: Parkinson’s Disease

It is a progressive and chronic disorder, caused by death or malfunctioning of neurons, genetic mutation leading to decreased level of dopamine secretion. Associated effects are anxietydepression, stress, ageing and neurodegenerative disorders, disease diagnostics, drug designing and therapeutics are the research areas.

Track 12: Molecular Neuropharmacology

Molecular neuropharmacology involves the study of neurons and agonist, Competitive antagonist and Non-competitive antagonist, receptors on neurons for developing new drugs that will treat neurological disorders of neurodegenerative diseases. Neurogenesis and repair refers to the growth and development of neuron. Neurons never function in isolation; they are organized into ensembles or circuits that process kinds of information which are referred as neuronal circuits. The GABA inhibitory neurotransmitter and serotonin neurotransmitter present in the central nervous system of mature vertebrate interacts with GABA receptor and 5HT receptor respectively. GABAA receptors are modulated by the channel of 5HT receptors through activation of various proteins. There are about 14 5HT receptor subtypes identified from last 20 years which are now researched for their significance in various disorders and treatments. Synaptopathy is a progressively popular term used to define main features of psychiatric and neurodegenerative diseases. It infers that brain diseases are resulted from disruption of synaptic structure and function.

Related Conferences: Neuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26- 27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 13th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; Mississippi Addictions Conference, February 28 -March 02 2018, Jackson, USA; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; British NeuroPsychiatry Meeting, March 01- 02 2018, London, UK; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, USA;  26th European Psychiatric Meeting, 3March 03-06 2018, Nice, France;  20th Parkinson’s Disease and Movement Disorders symposium, May 14 - 15, 2018, London, UK

Related Societies:

Societies in USA: American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, Alzheimer's Association

Societies in Europe: Alzheimer Europe, European Federation of Neurological SocietiesNational Institute of Neurological Disorders and Stroke, Australian Neuroscience SocietyAmerican Clinical Neurophysiology Society

Societies in Asia: Asian Society Against Dementia (ASAD),  Neurological Society of India, Neurology Asia, Austrian society of neurology, Asia Pacific Stroke Organisation

Track 13: Future Aspects of Neuropharmacology

Neuropharmacology is an emerging field of science, rising exponentially with the understanding of nervous system and its related disorders, drugs and treatments. The major area of research includes mechanisms of novel drugs, neuro stem cell therapy, immunoglobulin therapy, gene therapy in neuronal disorders and neural engineering.

Related Conferences: Neuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

13th European Pharma Conferences May 07-09, 2018 at Frankfurt, Germany; Mississippi Addictions Conference, February 28 -March 02 2018, Jackson, USA; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26- 27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; British NeuroPsychiatry Meeting, March 01- 02 2018, London, UK; International Stroke Conference 2018, January 24–26, 2018, Los Angeles, USA;  26th European Psychiatric Meeting, 3March 03-06 2018, Nice, France;  20th Parkinson’s Disease and Movement Disorders symposium, May 14 - 15, 2018, London, UK

Related Societies:

Societies in USA: American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN), American Neurological Association (ANA), American Society of Neuroimaging, Alzheimer's Association

Societies in Europe: Alzheimer Europe, European Federation of Neurological SocietiesNational Institute of Neurological Disorders and Stroke, Australian Neuroscience SocietyAmerican Clinical Neurophysiology Society

Societies in Asia: Asian Society Against Dementia (ASAD),  Neurological Society of India, Neurology Asia, Austrian society of neurology, Asia Pacific Stroke Organisation

About Conference

ConferenceSeries Ltd is a renowned organization that organizes highly notable  conferences throughout the globe. Currently we are bringing forth "9th Global Experts Meeting on Neuropharmacology” (Neuropharmacology 2018) scheduled to be held during June 18-19, 2018 at Paris, France. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmacologyand Neuropharmacology.

ConferenceSeries Ltd Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access Journals which contains over 70000 eminent personalities as editorial board members as reputed scientists and 1200+ Symposiums & Workshops. To know more about the conference series

Why to attend???

With members from around the world focused on learning about neuropharmacology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Neuropharmacology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Neuropharmacology are hallmarks of this conference.

Target Audience:

  • Neuropharmacology Students, Scientists
  • Neuropharmacology Researchers
  • Neuropharmacology Faculty
  • Medical Colleges
  • Neuropharmacology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies

2018 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

Supported By

Neurochemistry & Neuropharmacology: Open Access Journal of Neurological Disorders Journal of Neurology & Neurophysiology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos